The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression | Zendy

Johanna Protze | Zendy; Stephanie Naas | Zendy; René Krüger | Zendy; Christine Stöhr | Zendy; Andre Kraus | Zendy; Steffen Grampp | Zendy; Michael S. Wiesener | Zendy; Mario Schiffer | Zendy; Arndt Hartmann | Zendy; Bernd Wullich | Zendy; Johannes Schödel | Zendy

Open Access

The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression

Author(s) -

Johanna Protze,

Stephanie Naas,

René Krüger,

Christine Stöhr,

Andre Kraus,

Steffen Grampp,

Michael S. Wiesener,

Mario Schiffer,

Arndt Hartmann,

Bernd Wullich,

Johannes Schödel

Publication year - 2022

Publication title -

journal of biological chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.361

H-Index - 513

eISSN - 1067-8816

pISSN - 0021-9258

DOI - 10.1016/j.jbc.2022.101699

Subject(s) - biology , enhancer , transcription factor , clear cell renal cell carcinoma , cancer research , renal cell carcinoma , chromatin , hypoxia inducible factors , allele , single nucleotide polymorphism , chromatin immunoprecipitation , microbiology and biotechnology , genetics , genotype , gene , gene expression , medicine , promoter

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research